Decreased hepatic phosphatidylinositol-3,4,5-triphosphate (PIP3) levels and impaired glucose homeostasis in type 1 and type 2 diabetic rats

Cellular Physiology and Biochemistry

Volumn 30, Issue 6, 2012, Pages 1363-1370

  Manna, Prasenjit ^a   Jain, Sushil K ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Glucose metabolism; Livers; PIP2; PIP3; Type 1 and type 2 diabetic rats

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; GLUCOSE; GLUCOSE OXIDASE; GLUCOSE TRANSPORTER 2; GLYCOSYLATED HEMOGLOBIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; INSULIN DEPENDENT DIABETES MELLITUS; LIVER FUNCTION; LIVER FUNCTION TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALIA; RATTUS;

EID: 84867898269     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000343325     Document Type: Article

References (22)

1. Pendaries C, Tronchère H, Plantavid M, Payrastre B: Phosphoinositide signaling disorders in human diseases. FEBS Lett 2003;546:25-31. (Pubitemid 36782278)
2. Czech MP: PIP2 and PIP3: complex roles at the cell surface. Cell 2000;100:603-606.
3. Hinchliffe KA: Cellular signalling: stressing the importance of PIP3. Curr Biol 2001;11:R371-R372.
4. Park WS, Heo WD, Whalen JH, O'Rourke NA, Bryan HM, Meyer T, Teruel MN: Comprehensive identification of PIP3-regulated PH domains from C. elegans to H. sapiens by model prediction and live imaging. Mol Cell 2008;30:381-392. (Pubitemid 351615320)
5. Várnai P, Bondeva T, Tamás P, Tóth B, Buday L, Hunyady L, Balla T: Selective cellular effects of overexpressed pleckstrin-homology domains that recognize PtdIns (3, 4, 5) P3 suggest their interaction with protein binding partners. J Cell Sci 2005;118:4879-4888. (Pubitemid 41646394)
6. Lietzke SE, Bose S, Cronin T, Klarlund J, Chawla A, Czech M P, Lambright DG: Structural basis of 3-phosphoinositide recognition by pleckstrin homology domains. Mol Cell 2000;6:385-394.
7. Toker A The synthesis and cellular roles of phosphatidylinositol 4, 5-bisphosphate. Curr Opin Cell Biol 1998;10:254-261. (Pubitemid 28174768)
8. Taniguchi CM, Tran TT, Kondo T, Luo J, Ueki K, Cantley LC, Kahn CR: Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN. Proc Natl Acad Sci USA 2006;103:12093-12097. (Pubitemid 44215816)
9. Butler M, McKay RA, Popoff IJ, Gaarde WA, Witchell D, Murray SF, Dean NM, Bhanot S, Monia BP: Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes 2002;51:1028-1034. (Pubitemid 34438346)
10. Ono H, Katagiri H, Funaki M, Anai M, Inukai K, Fukushima Y, Sakoda H, Ogihara T, Onishi Y, Fujishiro M, Kikuchi M, Oka Y, Asano T: Regulation of phosphoinositide metabolism, AKT phosphorylation, and glucose transport by PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome 10) in 3T3-L1 adipocytes. Mol Endocrinol 2001;15:1411-1422. (Pubitemid 32703487)
11. Saltiel AR, Kahn CR: Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001;414:799-806 (Pubitemid 34000783)
12. Manna P, Jain SK: Hydrogen sulfide and L-cysteine increase phosphatidylinositol 3, 4, 5-trisphosphate (PIP3) and glucose utilization by inhibiting phosphatase and tensin homolog (PTEN) protein and activating phosphoinositide 3-kinase (PI3K)/serine/threonine protein kinase (AKT)/protein kinase Cζ/λ (PKCζ/λ) in 3T3L1 adipocytes. J Biol Chem 2011;286:39848-39859.
13. Funaki M, Di Fransico L, Janmey PA: PI-4, 5-P2 stimulates glucose transport activity of GLUT4 in the plasma membrane of 3T3-L1 adipocytes. Biochim Biophys Acta 2006;1763:889-899. (Pubitemid 44205276)
14. Gray A, Olsson H, Batty IH, Priganica L, Peter Downes C: Nonradioactive methods for the assay of phosphoinositide 3-kinases and phosphoinositide phosphatases and selective detection of signaling lipids in cell and tissue extracts. Anal Biochem 2003;313:234-245. (Pubitemid 36259947)
15. Levinthal GN, Tavill AS: Liver disease and diabetes mellitus. Clin Diabetes 1999;17.
16. Leturque A, Brot-Laroche E, Le Gall M, Stolarczyk E, Tobin V: The role of GLUT2 in dietary sugar handling. J Physiol Biochem 2005, 61:529-537.
17. Zhao FQ, Keating AF: Functional properties and genomics of glucose transporters. Curr Genomics 2007;8:113-128. (Pubitemid 46690959)
18. Jornayvaz FR, Shulman GI: Diacylglycerol activation of protein kinase Ce and hepatic insulin resistance. Cell Metab 2012;15:574-584.
19. Hwang JH, Perseghin G, Rothman DL, Cline GW, Magnusson I, Petersen KF, Shulman GI: Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. A 13C nuclear magnetic resonance spectroscopy study. J Clin Invest 1995;95:783-787
20. Aiston S, Peak M, Agius L: Impaired glycogen synthesis in hepatocytes from Zucker fatty fa/fa rats: the role of increased phosphorylase activity. Diabetologia 2000;43:589-597. (Pubitemid 30322077)
21. Slieker LJ, Sundell KL, Heath WF, Osborne HE, Bue J, Manetta J, Sportsman JR: Glucose transporter levels in tissues of spontaneously diabetic Zucker fa/fa rat (ZDF/drt) and viable yellow mouse (Avy/a). Diabetes 1992;41:187-193.
22. Yamamoto T, Fukumoto H, Koh G, Yano H, Yasuda K, Masuda K, Ikeda H, Imura H, Seino Y: Liver and musclefat type glucose transporter gene expression in obese and diabetic rats. Biochem Biophys Res Commun 1991;175:995-1002.